Tuesday, 17 November 2026 SEC EDGAR filings, as they land
ALFA USA News Straight from the SEC filing
SEC Filings
M&A Deal

Cencora Announces $2.4 Billion Acquisition of American Oncology Network

Cencora has signed a definitive agreement to acquire American Oncology Network for an enterprise value of $2.4 billion. The transaction integrates a network of over 350 oncology providers into Cencora's management services organization, significantly expanding its footprint across the United States. This move follows a series of large-scale specialty care acquisitions by Cencora to broaden its healthcare services portfolio.

Cencora Announces $2.4 Billion Acquisition of American Oncology Network
Cencora, Inc. · Healthcare · Representative image
Key numbers
Deal value$2.4B
Share of market cap3.7%
Share of annual revenue0.7%

Key highlights

  • Enterprise value of $2.4 billion includes $2.3 billion at closing and $100 million in contingent value rights
  • Acquisition adds more than 350 oncology providers across 21 states to Cencora’s MSO platform
  • Deal is expected to be accretive to Cencora’s adjusted diluted EPS in the second year post-closing
  • Cencora expects a cash outlay of $1.7 billion assuming a 25% equity rollover by certain stockholders
  • Transaction has been approved by AON’s Board of Directors following a special committee recommendation

What Is the Deal?

Cencora, Inc. has entered into a definitive merger agreement to acquire American Oncology Network (AON) for a total enterprise value of $2.4 billion. The consideration includes an upfront payment of $2.3 billion and additional contingent value rights (CVRs) of up to $100 million, payable upon the satisfaction of specific conditions. Cencora, which already holds a 4% equity interest in the target, will acquire all remaining shares. The deal structure allows for an equity rollover of up to 25% by existing AON stockholders, which would result in Cencora paying approximately $1.7 billion for a 75% stake at closing. The transaction is subject to regulatory approvals and AON stockholder consent.

Strategic Rationale

The acquisition is designed to expand Cencora’s physician-led oncology management services organization (MSO) by adding a footprint in 12 additional states. By bringing AON’s network of over 350 providers under its umbrella, Cencora aims to strengthen community-based cancer care and improve patient access to innovative therapies. The integration of AON is expected to enhance practice support capabilities and technological infrastructure for independent oncology practices. This alignment leverages Cencora's global pharmaceutical supply chain to support AON’s mission of delivering high-quality care in local settings. Clinical autonomy will remain with AON’s physicians following the completion of the merger.

Financial Context

This $2.4 billion transaction follows a period of aggressive expansion for Cencora in the specialty healthcare sector, including the $5.0 billion majority interest acquisition of OneOncology and the $4.6 billion purchase of Retina Consultants of America. Cencora recently updated its fiscal 2026 financial expectations, guiding for adjusted diluted earnings per share of at least $17.90. The company’s market capitalization stands at approximately $65.5 billion, and it reported annual revenue of $321.3 billion. This acquisition is projected to become accretive to adjusted diluted EPS in the second year after the transaction closes, reinforcing Cencora’s strategy of pivoting toward high-margin specialty services.

Cencora, Inc. share price · last month
Line chart of Cencora, Inc.'s share price over the last month, from $340.00 on 19 Oct → $356.94 on 16 Nov; our story on 21 Oct at $343.27.

Up 4.0% since our story on 21 Oct: $343.27 when we broke it → $356.94 at the close on 16 Nov. Daily closing prices. Source: Yahoo Finance.

Show the prices
19 Oct$340.00
20 Oct$343.27
21 Oct$340.43
22 Oct$338.48
23 Oct$331.00
26 Oct$330.00
27 Oct$325.37
28 Oct$324.35
29 Oct$330.53
30 Oct$330.84
2 Nov$337.84
3 Nov$340.50
4 Nov$354.00
5 Nov$339.68
6 Nov$333.56
9 Nov$345.76
10 Nov$348.71
11 Nov$349.88
12 Nov$349.38
13 Nov$359.03
16 Nov$356.94

Industry Landscape

  • Consolidation in community oncology continues as providers seek scale to manage rising operational costs
  • The acquisition follows Cencora's $1.1 billion purchase of EyeSouth Partners' retina business in March 2026
  • Specialty healthcare services are becoming a primary growth engine for major medical distributors
  • Regulatory focus on vertical integration in the pharmacy and provider sectors remains a key variable for deal completion
  • Market sentiment for Cencora is currently high, evidenced by an RSI of 70.8 and a 11.7% quarterly price increase
Earlier announcements by Cencora, Inc.
DateAnnouncementAmount
23 Mar 2026Acquisition of EyeSouth Partners' retina businessSource: healthcaredive.com$1.10 Billion
18 Feb 2026Merger and divestiture of MWI Animal Health with CovetrusSource: investor.amerisourcebergen.com$3.50 Billion
15 Dec 2025Acquisition of majority interest in OneOncologySource: fiercehealthcare.com$5.00 Billion
13 Oct 2025Acquisition of NextPharma Logistics GmbHSource: nextpharma.com–
06 Nov 2024Acquisition of Retina Consultants of AmericaSource: SEC filing$4.60 Billion

Management commentary

“The acquisition of AON will expand our physician-led oncology MSO and support of care in communities across the country.”

Robert P. Mauch, President and Chief Executive Officer of Cencora

“This is the next chapter of the same mission: high-quality, accessible cancer care delivered close to home, led by physicians who know their patients best.”

Todd Schonherz, Chief Executive Officer of American Oncology Network
Cencora, Inc. · financial snapshot
Share price$343.27
Market cap$65.5B
Revenue (annual)$321.3B
P/E (TTM)25.5×
1-month price change+11.17%
SectorHealthcareMedical Distribution

Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.

Source verified

SEC filing by Cencora, Inc. announcing a definitive agreement to acquire American Oncology Network for $2.4 billion.

Read the filing ↗

Track Cencora, Inc. live

Get the next Cencora, Inc. SEC filing seconds after it lands.

More in M&A & Deals

All →

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.